Holdings
PGIM Jennison Health Sciences Fund
As of May 29, 2026, PGIM Jennison Health Sciences Fund reported 52 positions worth US$1.36B. Largest: Eli Lilly And Company, Merck & Company, Inc. and Unitedhealth Group Incorporated. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 218K | US$241M | −14,558 | May 29, 2026 |
| Merck & Company, Inc. | 709K | US$84.2M | no change | May 29, 2026 |
| Unitedhealth Group Incorporated | 214K | US$81.5M | no change | May 29, 2026 |
| Thermo Fisher Scientific Inc | 128K | US$63.3M | +50,396 | May 29, 2026 |
| Argenx Se | 59,035 | US$49.4M | no change | May 29, 2026 |
| Vertex Pharmaceuticals Incorporated | 104K | US$46.7M | no change | May 29, 2026 |
| Danaher Corporation | 250K | US$45.6M | +38,668 | May 29, 2026 |
| Intuitive Surgical, Inc. | 101K | US$42.7M | new | May 29, 2026 |
| Lonza Group Ag | 65,672 | US$41.9M | no change | May 29, 2026 |
| Cvs Health Corporation | 385K | US$35M | −213K | May 29, 2026 |